Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in sun pharmaceuticals

Nifty, Sensex Up For Sixth Day, Hindustan Unilever Gets Horlicks Boost

The broader NSE Nifty closed 0.06 per cent higher at 10,883.75, while the benchmark Sensex index ended 0.13 higher at 36,241. Both indexes marked their sixth successive session of gains

Read More

Dr Reddy’s, Sun Pharma, Glenmark Face US price Fixing Charge

The states are seeking to expand the complaint to include Actavis Holdco US, Actavis Pharma, Ascend Laboratories, Apotex Corp, Dr Reddy’s Laboratories (DRL), Emcure Pharmaceuticals, Glenmark Pharmaceuticals, Lannett Company, etc.

Read More

Sun Pharma Took Two Years To Integrate Ranbaxy’s Employees

While Sun Pharmaceuticals started out the process of easing out excess employees from Ranbaxy, company also undertook several initiatives to relax and motivate the rest

Read More

Sun Pharma Says FDA To Lift Ban On Mohali Drug Plant

Sun Pharmaceutical Industries said on Tuesday that US regulators plan to lift a ban on its Mohali plant in Punjab, allowing the company to restart supplies from there after four years

Read More

US FDA Finds Quality Control Problems At Sun Pharma's Halol Plant

The US Food and Drug Administration has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report obtained by Reuters shows

Read More

Sun Pharma Says US Finds More Concerns At Halol Plant

Sun Pharmaceutical Industries said on Wednesday the US health regulator has informed the company of more concerns found at its Halol manufacturing plant after a recent inspection

Read More

Sun Pharma To Shut Some Plants In India, Overseas

Sun Pharmaceutical Industries Ltd will shut down some of its manufacturing plants in India as well as overseas as the company will continue trimming its large manufacturing base as part of cost optimisation

Read More

FDA Warns Former Sun Pharma US Drug Factory Over Quality Concerns

The plant was sold to Frontida in June by Sun, India's No. 1 drugmaker, which said the move was 'a part of its manufacturing consolidation in the US'

Read More

Sun Pharma First-quarter Profit Boosted By Gleevec Generic

Sun Pharmaceutical Industries reported a quarterly profit that beat analysts' estimates, helped by its exclusive launch of the first generic version of leukaemia drug Gleevec in the United States

Read More

Sun Pharma Bets On New Products To Boost US Skincare Products Growth

Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative US dermatology business

Read More

Sun Pharma Enters Dermatology Segment To Expand Retail Offering

The world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product

Read More

Sun Pharma Q4 Net Up 93 Per Cent On Exclusivity Sales In US, Low cost

Sun Pharma’s formulation sales in the United States at $580 million during the quarter grew 19 per cent over the last year

Read More

Sun Pharma Gets US Subpoena Over Generic Drugs Pricing

The DoJ's antitrust division has also asked Sun Pharma's US unit for documents related to employee and corporate records and communications with competitors

Read More

Lupin Says It Sees No Supply Disruption At Plant Despite FDA Observations

The company said it did not expect any disruption to supply from its main manufacturing plant despite what it called minor observations made by the US Food and Drug Administration after an audit

Read More

Sun Pharma: Acquiring Growth

Sun Pharma, promoted and led by the astute billionaire, Dilip Shanghvi, has always followed an inorganic growth strategy both in India and abroad.

Read More